trial · primary record
Povetacicept
Myasthenia Gravis, Generalized
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 34 |
| Primary completion | 2029-03-02 |
| Primary endpoint | Percent change in Total Immunoglobulin G (IgG) |
| Registry ID | NCT07501702 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:53.524Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07501702
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.